This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Larimar Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Thomas Ransohoff: Innovator in Pharmaceutical Composition
Introduction
Thomas Ransohoff is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of genetic disorders. His work focuses on innovative solutions that address critical health issues.
Latest Patents
Ransohoff holds a patent for a pharmaceutical composition comprising a frataxin fusion protein. This patent, titled "Pharmaceutical composition comprising frataxin fusion protein and methods of use thereof," outlines the use of a TAT-FXN fusion polypeptide. The methods described in the patent aim to treat subjects diagnosed with Friedrich's Ataxia and/or hypertrophic cardiomyopathy. This innovative approach has the potential to improve the quality of life for patients suffering from these conditions.
Career Highlights
Ransohoff is currently associated with Larimar Therapeutics, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative therapies in addressing unmet medical needs.
Collaborations
Ransohoff collaborates with Denis Boyle, a fellow professional in the field. Their partnership exemplifies the collaborative spirit that drives innovation in pharmaceutical research.
Conclusion
Thomas Ransohoff is a dedicated inventor whose work in pharmaceutical compositions is paving the way for new treatments for serious health conditions. His contributions are vital to the ongoing efforts in medical research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile